Skip to main content

Verified Treatment Center

Gaudenzia Withdrawal Stabilization and Assessment Center

Philadelphia, PA · 19123

SAMHSA Verified Inpatient MAT Dual Dx
Specializes in Dual Diagnosis

Key Takeaways for Gaudenzia Withdrawal Stabilization and Assessment Center

  • Inpatient · MAT · Dual Dx offered
  • Accepts Medicaid, Medicare, Private insurance
  • SAMHSA-listed facility
  • Direct line available · Helpline free & confidential 24/7

About Gaudenzia Withdrawal Stabilization and Assessment Center

Located in Philadelphia, PA, Gaudenzia Withdrawal Stabilization and Assessment Center operates within the PA regulatory framework as a licensed addiction-treatment provider. The facility offers a continuum of care across multiple levels — Inpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.

Care levels at Gaudenzia Withdrawal Stabilization and Assessment Center

The facility offers a continuum of care across multiple levels — Inpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Gaudenzia Withdrawal Stabilization and Assessment Center provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.

Insurance and payment

Payment and insurance posture: Gaudenzia Withdrawal Stabilization and Assessment Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.

Specialty programming

The facility's documented specialty programming includes: Clients with co-occurring mental and substance use disorders. Clinical verification of specialty programming should encompass credentialed staff profile, programming-hour documentation, and specialty-specific medical-necessity documentation for third-party authorization. The MHPAEA 2024 rule addresses specialty-program network adequacy for patients requiring specific clinical capabilities.

Before you call

Operational admission checklist for Gaudenzia Withdrawal Stabilization and Assessment Center: (a) clinical assessment with documented ASAM 4e level-of-care recommendation; (b) insurance benefits verification in writing; (c) MAT policy documentation; (d) accreditation and licensure verification; (e) confirmed prior authorization for specific level of care. Each should be obtained in written form prior to admission. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.

Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.

Gaudenzia Withdrawal Stabilization and Assessment Center at a Glance

Levels of care

Inpatient · MAT · Dual Dx

Service settings

Residential/24-hour residential, Long-term residential, Short-term residential

Therapy approaches

Anger management, Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy

Age groups

Young Adults, Adults

Special populations

Clients with co-occurring mental and substance use disorders

Medications

Buprenorphine with naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Medication for mental disorders

Insurance & Payment Accepted

Confirm in-network status before admission — verification is free.

Private insurance

Coverage details →

TRICARE / VA

Contact & Location

Address

1306 Spring Garden Street, Philadelphia, PA 19123

Facility direct line

(888) 410-5186